Skip to content

Frontlight ResearchEarly access

Trial site

CenExel Clinical Innovations, Inc.

Riverside, California 92506, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Schizophrenia

Closed trials

Completed
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
NCT05145413· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

CenExel Clinical Innovations, Inc.: trial site – Frontlight Research